|
Market Closed -
Nasdaq
00:00:00 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 21.35 USD | +0.99% |
|
+4.25% | +69.44% |
| 10-28 | US estrogen supply crunch widens as women seek alternatives to scarce patches | RE |
| 09-23 | Amneal Pharmaceuticals' Biosimilars, Specialty Growth Reshape Earnings Profile, Oppenheimer Says | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMRX | Delayed | |
CBOE
| AMRX | Real-time | |
|
Tradegate
| 2DT | Real-time | |
|
Deutsche Boerse AG
| 2DT | Delayed | |
|
Börse Stuttgart
| 2DT | Delayed | |
|
Boerse Muenchen
| 2DT | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 21.44 | 21.44 | 24.09 |
| Spread/Res. | -0.42% | -0.42% | -11.37% |
| Spread/Supp. | +4.91% | +28.23% | +30.10% |
| Support | 20.35 | 16.65 | 16.41 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMRX Stock
- Charts Amneal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
